INDIVIOR PHARMACEUTICALS INC (INDV)
NASDAQ • Healthcare
Last close at August 11, 2026 at 20:00 UTC
Fundamentals Charts
About INDIVIOR PHARMACEUTICALS INC
Indivior Pharmaceuticals Inc is a healthcare holding company that researches, produces, and distributes buprenorphine-based prescription medications designed to treat opioid dependence. Listed on the NASDAQ as INDV, it generated $1.2 billion of revenue in FY2025 from a portfolio centered on addiction-treatment therapies.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
INDIVIOR PHARMACEUTICALS INC's Technical Indicators Summary
INDV reads as a sell given that short- and medium-term moving averages sit at or above the market and momentum measures are skewed negative, including a negative MACD and declining short-term momentum. Trend strength is muted, volatility is relatively elevated as reflected in a multi-percent ATR, and on-balance volume aligns with selling pressure, while longer-term averages remain below the current price and provide some structural support. Technical takeaway: Sell — short-to-intermediate bearish signals and weak volume outweigh longer-term average support.
| Indicator | Value |
|---|---|
RSI (14) | 45.16 |
Stochastic %K (14, 3, 3) | 46.04 |
CCI (20) | -64.98 |
WPR (14) | -53.23 |
Momentum (10) | -1.59 |
MFI | 33.75 |
MACD Level (12, 26) | -0.38 |
Bollinger Bands | $37.01 - $41.90 |
ATR (14) | $1.52 (3.94%) |
ADX (14) | 17.46 |
OBV | 4,293,019 |
Classic Pivot Point | $38.70 |
Fibonacci Pivot Point | $38.70 |
Simple Moving Averages | $35.01 - $39.45(5 indicators) |
Exponential Moving Averages | $34.36 - $39.15(5 indicators) |
Get premium market insights delivered directly to your inbox.